<?xml version="1.0"?>
<rss version="2.0">
  <channel>
    <title>RxPG News : Entecavir</title>
      <link>http://www.rxpgnews.com/</link>
      <description>Medical News and Information</description>
      <pubDate>Thu, 21 Aug 2008 02:00:28 PST</pubDate>
      <language>en-us</language>
      <item>
        <title>Baraclude (Entecavir) For Treatment Of Chronic Hepatitis B approved by FDA</title>
        <link>http://www.rxpgnews.com/entecavir/Baraclude_Entecavir_For_Treatment_Of_Chronic_Hepat_896_896.shtml</link>
        <category>Entecavir</category>
        <description>Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food and Drug Administration (FDA) approved Baraclude (entecavir). </description>
        <pubDate>Thu, 31 Mar 2005 21:26:00 PST</pubDate>
        <guid isPermaLink="true">http://www.rxpgnews.com/entecavir/Baraclude_Entecavir_For_Treatment_Of_Chronic_Hepat_896_896.shtml</guid>
      </item>


  </channel>
</rss>
